|
Search
Collections
Benchmarks
Upload document
Organization
Sapu Bioscience LLC
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
The prognostic impact of transforming growth factor beta 2 (TGFB2) mRNA levels, in conjunction with interferon-gamma receptor activation of interferon regulatory factor 5 (IRF5) and expression of CD276/B7-H3 in low-grade gliomas.
Org:
Sapu Bioscience LLC,
Oncotelic Therapeutics,
